Label Changes for:
Starlix (nateglinide) tablets
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August 2011
- Certain drugs including ……., somatropin, rifampin,phenytoin and dietary supplements (St John’s wort) may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs. Somatostatin analogues may potentiate or attenuate the hypoglycemic action of Starlix.